TY - JOUR
T1 - A Novel Truncating Variant in FLNC-Encoded Filamin C May Serve as a Proarrhythmic Genetic Substrate for Arrhythmogenic Bileaflet Mitral Valve Prolapse Syndrome
AU - Bains, Sahej
AU - Tester, David J.
AU - Asirvatham, Samuel J.
AU - Noseworthy, Peter A.
AU - Ackerman, Michael J.
AU - Giudicessi, John R.
N1 - Funding Information:
Potential Competing Interests: Dr Ackerman is a consultant for Audentes Therapeutics, Boston Scientific, Gilead Sciences, Invitae, Medtronic, MyoKardia, and St. Jude Medical. Dr Ackerman and Mayo Clinic have potential equity/royalty relationships (without remuneration so far) with AliveCor, Blue Ox Health, and StemoniX. Dr Ackerman has received a research grant from the National Institutes of Health and owns stock/stock options in AliveCor. However, none of these entities participated in this study. The other authors report no competing interests.
Publisher Copyright:
© 2018 Mayo Foundation for Medical Education and Research
PY - 2019/5
Y1 - 2019/5
N2 - A 51-year-old man with a long-standing history of bileaflet mitral valve prolapse accompanied by mitral annular disjunction and mild mitral regurgitation presented for evaluation of increasingly frequent palpitations. Ambulatory Holter monitoring, cardiac magnetic resonance imaging, serial transthoracic echocardiography, and diagnostic electrophysiology studies were consistent with a diagnosis of arrhythmogenic bileaflet mitral valve prolapse syndrome. Because of the presence of a similar phenotype in the proband's mother, brother, and maternal aunt, research-based whole exome sequencing was pursued and a novel truncating variant (p.Trp34*-FLNC) in the cardiomyopathy-causative FLNC-encoded filamin C unearthed that cosegregated with disease. Unexpectedly, these observations provide the first evidence that a heritable proarrhythmic genetic substrate (ie, FLNC haploinsufficiency–mediated weakening of cell-cell adhesion) may underlie, at least in part, some cases of arrhythmogenic mitral valve prolapse syndrome.
AB - A 51-year-old man with a long-standing history of bileaflet mitral valve prolapse accompanied by mitral annular disjunction and mild mitral regurgitation presented for evaluation of increasingly frequent palpitations. Ambulatory Holter monitoring, cardiac magnetic resonance imaging, serial transthoracic echocardiography, and diagnostic electrophysiology studies were consistent with a diagnosis of arrhythmogenic bileaflet mitral valve prolapse syndrome. Because of the presence of a similar phenotype in the proband's mother, brother, and maternal aunt, research-based whole exome sequencing was pursued and a novel truncating variant (p.Trp34*-FLNC) in the cardiomyopathy-causative FLNC-encoded filamin C unearthed that cosegregated with disease. Unexpectedly, these observations provide the first evidence that a heritable proarrhythmic genetic substrate (ie, FLNC haploinsufficiency–mediated weakening of cell-cell adhesion) may underlie, at least in part, some cases of arrhythmogenic mitral valve prolapse syndrome.
UR - http://www.scopus.com/inward/record.url?scp=85063479248&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063479248&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2018.11.028
DO - 10.1016/j.mayocp.2018.11.028
M3 - Article
C2 - 30935706
AN - SCOPUS:85063479248
SN - 0025-6196
VL - 94
SP - 906
EP - 913
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 5
ER -